Hyperglycemia or Hypoglycemia with Changes in Insulin Regimen: Changes in an insulin regimen (e.g., insulin strength, manufacturer, type, injection site or method of administration) may affect glycemic control and predispose to hypoglycemia or hyperglycemia.Sharing poses a risk for transmission of blood-borne pathogens. Never share a Fiasp ® FlexTouch ® Pen, PenFill ® cartridge or PenFill ® cartridge device between patients, even if the needle is changed. Patients using Fiasp ® vials must never share needles or syringes with another person.Fiasp ® is contraindicated during episodes of hypoglycemia and in patients hypersensitive to Fiasp ® or one of its excipients.
Important Safety Information Contraindications Indications and Usage for Fiasp ® (insulin aspart) injection 100 U/mLįiasp ® (insulin aspart) injection 100 U/mL is a rapid-acting insulin analog indicated to improve glycemic control in adult and pediatric patients with diabetes mellitus.
